Phase II/III of Recombinant Human Serum Albumin

Clinical trial NCT05858853 · COMPLETED

Trial details

NCT number: NCT05858853
Sponsor: Protgen Ltd
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cirrhotic Ascites

Start date: 2023-05-24
Primary completion: 2023-09-15
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.